Radio Advisory

As healthcare organizations look for ways to weather financial hardships, many leaders are looking at strategic partnerships to sustain their business. The word "partnership" gets thrown around a lot in healthcare and can mean a lot of different things. But what defines a good partnership, and how do you know if one is right for your organization? In this episode, Host Rachel (Rae) Woods invites John Muir Chief Strategy Officer George Sauter and President of Optum's Market Performance Partnership Chris Pass to discuss why they decided to partner back in 2019, what they've gained, where they had to compromise, and how they define success. Have a healthcare question? Want to learn more about what goes on behind-the-scenes at Radio Advisory? Submit your question and we may use it in our final episode of 2024! Email podcasts@advisory.com or leave us a voice message by Thanksgiving for consideration. Thanks! Links: Deep dive: 5 partnership models in commercial risk 4 signs your VBC arrangement isn't a true partnership [Webinar] Playbook for Partnership (Part 2): Five Principles For Effective Relationships Our Leadership playlist Our Strategy playlist Join Advisory Board for a webinar on November 13 at 1pm EST to learn about recent trends and growing capabilities in remote patient monitoring. Click here to learn more. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

In recent years the delivery system has been strapped, to say the least. Any opportunity for financial stabilization and revenue diversification are sitting top of mind for provider executives. One place organizations are searching for lifelines is overseas, as more and more health systems are partnering internationally. No, it’s not just med tech and life sciences going global – health systems are looking overseas to advance their business objectives as well. In this episode, host Rachel (Rae) Woods invites Advisory Board international experts Paul Trigonoplos and Isis Monteiro to discuss why interest in global partnerships are accelerating, how organizations are leveraging these partnerships, and whether it’s a good idea for all health systems to go global. Ask us a question and hear it on the pod! Email us at podcasts@advisory.com, visit ask.advisory.com, or leave a voicemail at radioadvisory.advisory.com. Links: Ep. 152: The global workforce crisis (and possible solutions) We polled 50+ health system executives on their global partnership strategy. 3 things surprised us. 5 goals health systems are pursuing through international ventures Your guide to global health system partnerships The 5 things we're watching in international healthcare in 2023 Join Advisory Board experts on Thursday, November 2 at 1 p.m. ET for a webinar where you’ll learn everything you need to know about the different types of AI, how these technologies are being used by healthcare organizations, common implementation pitfalls – and how to avoid them. Visit advisory.com/AIstrategy and register now. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

In recent decades, billions of dollars have gone towards programs aimed at curbing obesity in the U.S., yet the prevalence of obesity remains high. Weight management drugs like Ozempic and Wegovy have come to public awareness recently, though these drugs are often expensive and hard to access, leaving patients to receive the industry's traditional approach to weight management. But are these approaches even helpful? In this episode, host Rachel Woods invites health equity expert Darby Sullivan and pharmacy expert Chloe Bakst to discuss how the healthcare industry thinks about weight management, why the current approaches may be doing more harm than good, and how healthcare leaders need to think differently about treating obesity and weight. Ask us a question and hear it on the pod! Email us at podcasts@advisory.com, visit ask.advisory.com, or leave a voicemail at radioadvisory.advisory.com. Links: Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs 3 missteps in our approach to treating obesity (and 5 ways to fix it) The 5 biggest weight management drug questions (and our answers) What the headlines get wrong about weight-management medications Learn about Advisory Board Sponsorship at advisory.com/sponsorship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

In last week's episode, we discussed why technology is a non-negotiable tool for alleviating the workforce crisis. While we talked about many technologies, we didn't talk much about one of the most transformational forces in the healthcare industry today: Artificial Intelligence. There is so much buzz, and so much fear about the topic, that we wanted to dedicate an episode to it. In this episode host Rachel (Rae) Woods invites back fan-favorite guest Tom Lawry, a top thought leader on artificial intelligence, bestselling author, and the former head of AI for Microsoft. Last year, Tom was part of an award-winning Radio Advisory episode on bias and AI. In this episode, Rae and Tom will discuss frustrations, fears, and the wealth of opportunities that generative AI brings the healthcare industry. They also discuss myths around AI, and why leaders should stop worrying about existential threats and start imagining the existential opportunity this technology provides. Links: Ep. 138: Microsoft's head of AI on building ethical systems Ep. 179: Future-proofing healthcare requires a tech-enabled workforce How will AI change healthcare? Look at the internet for parallels. Generative artificial intelligence TomLawry.com Visit advisory.com/AI101 to learn more about Advisory Board's upcoming AI and Generative AI 101 webinar. Learn more about how you can make the best use of AI and prepare your organization for the future with Advisory Board's Expert Support. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

It's no secret that the industry is in the midst of a serious workforce crisis. For years, leaders have employed strategies primarily looking to mitigate the crisis with short-term solutions without addressing the root-causes of clinician burnout and workforce shortages. However, today we want to talk about a non-negotiable tactic that can work to address these root problems: technology. In this episode, host Rachel (Rae) Woods invites Advisory Board experts Allyson Paiewonsky and Jordan Peterson to discuss what organizations are getting wrong about tech and how it can work to sustainably alleviate the workforce crisis in the long term. Throughout the conversation, they discuss emerging technologies, why the industry needs to think differently about workforce solutions, and how leaders can work with the resources that they already have. Links: Ep. 173: 4 ways to prevent a physician shortage [Bonus content] Ep. 162: Addressing the workforce crisis: Insights from University Hospitals' leaders 12 technologies to address your clinical workforce challenges How technology can help solve the workforce crisis Learn more about the Advisory Board Fellowship at: advisory.com/fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Value-based care has been dominating industry conversations in recent years. Here on Radio Advisory, we talk a lot about best practices, how to make the right investments, and how to best prepare leaders for the future of value-based care. But given all this momentum, we want to spend time asking the question: what are the misconceptions or misaligned expectations that leaders have around value-based care? In this episode, host Rachel (Rae) Woods invites Advisory Board value-based care expert Daniel Kuzmanovich and Optum Advisory Service's SVP of value-based care, Erik Johnson, to discuss the mindset shifts they think leaders should be making when pursuing a sustainable value-based care strategy. Throughout the conversation they discuss what leaders are currently getting wrong, how myths about value-based care are impacting the industry, and more. Links: Ep. 172: Build a value-based enterprise: Live from 2023 Value-Based Care Summit Ep. 126: [Bonus content] Commercial risk is possible—here's how How Health Plans Can Support Providers in Risk The climb to value-based care [Upcoming Roundtable, Nov. 9-10] Shaping the New Era of Value-Based Care Learn more about Advisory Board's value-based care on-demand courses Explore what volumes and revenues a structural heart program could capture in different scenarios, with Advisory Board's new calculator, sponsored by Edwards Lifesciences. Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

With so many clinical innovations abound, it's easy to get excited about groundbreaking drugs, consumer technologies and even possible cures for rare diseases. However, the industry must recognize its own limitations in order to make these advancements accessible and equitable. At the end of August, hundreds of healthcare leaders gathered at Advisory Board's Clinical Innovation Summit in Minneapolis to learn about the implications of the transformation of patient care across the industry. The Radio Advisory team orchestrated a live podcast recording with thought leaders across the industry to talk about embedding equity in innovation. In this special live episode of Radio Advisory, host Rachel (Rae) Woods invites Maia Laing, SVP of Health Equity for UnitedHealth Group, and Michael Mejia, Advisory Board's director of life sciences research, to discuss how leaders can think about deploying, designing, and financing clinical innovations in an equitable way. Throughout the conversation, they discuss how payers and providers – not just life sciences – can rethink their practices to ensure advancements in innovation are shared equitably. Links: Dive into topics like AI and weight management drugs at Advisory Board’s Virtual Clinical Innovation Summit, coming up on October 4-5. Learn more and register. 7 trends shaping life sciences strategies in 2023 Health Equity landing page Learn more about Advisory Board Summits Need a quick answer to a healthcare question? Ask Advisory! Whether it's about where the market is headed, or how to navigate our website our team of experts are just a call or email away. Visit ask.advisory.com or email ask@advisory.com to learn more. Advisory Board is a subsidiary of UnitedHealth Group. All Advisory Board research, expert perspectives, and recommendations remain independent.

With rising costs and tightening margins, the industry is continually looking for ways to "bend the cost curve" while maintaining, or even increasing, quality and performance. One stakeholder in particular, employers, are feeling significant pressures from inflation, hospital consolidation, the rise of high-cost drugs, and more. While many legacy cost-saving strategies have focused on reducing employer costs, it may be time to shift focus to lowering costs for employees as well. In this episode, host Rachel (Rae) Woods invites Advisory Board payer expert Max Hakanson and Innovation lead at JPMorgan's Morgan Health Rivka Friedman to discuss what employers can do to rein in healthcare costs, both for themselves and their employees. Throughout the discussion, they discuss why legacy cost-sharing strategies may be insufficient, and what new innovations are showing promise in the market. Join Rae for a free webinar on Advisory Board's State of the Healthcare Industry. In this webinar, you'll get Advisory Board’s exclusive take on the strategic forces that really matter. Rae will talk about the rise of artificial intelligence and why you should not be asking "what should my AI strategy be?". Save your seat and join Rae on September 18th at 2:00 PM ET. Links: Home | Morgan Health Ep. 165: Employer series: Is the cost of employer-sponsored insurance unsustainable? Investigating the high costs in employer-sponsored insurance 5 health benefits strategies for self-funded employers 3 things to know about ESI (that you won't find in a benefits survey) Need a quick answer to a healthcare question? Ask Advisory! Whether it's about where the market is headed, or how to navigate our website our team of experts are just a call or email away. Visit ask.advisory.com or email ask@advisory.com to learn more.

This week’s episode comes from one of our favorite healthcare podcasts, See You Now, which shines a light on the real people changing the status quo in health, created in collaboration with Johnson & Johnson and the American Nurses Association. Racism in America remains pervasive. It’s led to sicker, shorter lives for people of color; a healthcare workforce that hasn’t reflected the communities it cares for; and caused harm to nursing and nurses, particularly nurses of color. Aware of its own role in perpetuating systemic racism, the American Nurses Association (ANA) is on a journey of racial reckoning along with many partners inside and outside of nursing and healthcare. In this two-part episode, we hear from leaders in nursing, media, and life sciences industry about how they are leaning into racial reckoning in their organizations to address and eliminate the harms of racism. In Part I, Shawna Butler, RN MBA and co-host Lucinda Canty, PhD, CNM, FACNM engage in thoughtful and forthright dialog with Cheryl Peterson, MSN, RN about the ANA's Racial Reckoning Statement; how it led to the creation of the National Commission to Address Racism in Nursing; and the work the ANA has committed to in moving forward to antiracist practices, policies, and nursing profession. Links: [See You Now] Episode 91: Reckoning with Racism (Part I) Shawna Butler, RN MBA Lucinda Canty, PhD, CNM, FACNM Cheryl Peterson, MSN, RN Visit the See You Now podcast site: www.seeyounowpodcast.com Free CNE's from the ANA for listening to See You Now episodes Episode-specific resources: ANA: Our Racial Reckoning Statement National Commission to Address Racism in Nursing Racial Discrimination in Healthcare: How Structural Racism Affects Healthcare Structural Racism In Historical And Modern US Health Care Policy The Sum of Us: What Racism Cost Everyone and How We Can Prosper Together What Racism Costs Us All New survey shows racism is a huge problem in nursing Key Takeaways from ANA's Racial Reckoning Statement Advisory Board resources on health equity and racism: Our health equity and racism Playlist 4 ways to develop a 'speak up' culture at your organization Health Equity landing page The time is now to invest in your BIPOC leaders. Build an inclusive leadership team with Advisory Board Fellowship. Learn more about Advisory Board on-demand courses

This week, we are revisiting episode 2 of our "Senior Care Series" from February 2023. This episode is still very relevant, but we do have some important updates that we’ve included at the beginning. Medicare Advantage is a public-private hybrid health plan that allows eligible seniors to receive health insurance through a commercial insurer. It has a high satisfaction rate among enrollees and has crested more than fifty percent of all Medicare enrollment this year. In part two of Radio Advisory's senior care series, host Rachel (Rae) Woods provides an update on new policies and regulatory scrutiny that are impacting the program. We also will revisit her conversation with senior care expert Aaron Hill and health plan expert Max Hakanson about why Medicare Advantage is so popular and its impact on industry stakeholders. Links: Ep. 150: Senior Care (Part 2): The rapid growth of Medicare Advantage Ep. 149: Senior Care (Part 1): Specialized primary care for an aging population Achieving sustainable growth in Medicare Advantage 9 data-driven insights on senior preferences when selecting a Medicare Advantage plan Shifting the balance of VBC in Medicare Advantage 2024 Risk Adjustment Data Validation final rule Learn more about Advisory Board On-Demand Courses Take our RN workforce survey at: advisory.com/RNsurvey